129 related articles for article (PubMed ID: 3927997)
41. Lymphoma cell line (FL-18) and Epstein-Barr virus-carrying cell line (FL-18-EB) obtained from a patient with follicular lymphoma: monoclonal derivation and different properties.
Doi S; Ohno H; Tatsumi E; Arita Y; Kamesaki H; Fukuhara S; Nishikori M; Miwa H; Kita K; Hatanaka M
Blood; 1987 Nov; 70(5):1619-23. PubMed ID: 2822175
[TBL] [Abstract][Full Text] [Related]
42. Pleural effusion as the first sign of multiple myeloma.
Uskül BT; Türker H; Emre Turan F; Unal Bayraktar O; Melikoğlu A; Tahaoğlu C; Oz B
Tuberk Toraks; 2008; 56(4):439-42. PubMed ID: 19123081
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
44. Development of myeloma and secondary myelodysplastic syndrome from a common clone.
Schmetzer HM; Mittermüller J; Duell T; Wilmanns W
Cancer Genet Cytogenet; 1998 Jan; 100(1):31-5. PubMed ID: 9406577
[TBL] [Abstract][Full Text] [Related]
45. Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review.
Sasser RL; Yam LT; Li CY
Acta Cytol; 1990; 34(4):479-85. PubMed ID: 2197839
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a novel myeloma cell line, MM.1.
Goldman-Leikin RE; Salwen HR; Herst CV; Variakojis D; Bian ML; Le Beau MM; Selvanayagan P; Marder R; Anderson R; Weitzman S
J Lab Clin Med; 1989 Mar; 113(3):335-45. PubMed ID: 2926241
[TBL] [Abstract][Full Text] [Related]
47. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.
Harashima A; Matsuo Y; Nishizaki C; Kozuka T; Fukuda S; Sezaki T; Orita K
Hum Cell; 2000 Mar; 13(1):43-54. PubMed ID: 10937346
[TBL] [Abstract][Full Text] [Related]
48. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
49. [An autopsy case of IgA (kappa) multiple myeloma characterized with pleural fluid and multiple extramedullary tumor formation].
Sugawara M; Sugaya N; Wakabayashi Y; Hirose S
Rinsho Ketsueki; 1987 Dec; 28(12):2133-9. PubMed ID: 3133508
[No Abstract] [Full Text] [Related]
50. Novel human multiple myeloma cell line UHKT-893.
Uherková L; Vančurová I; Vyhlídalová I; Pleschnerová M; Spička I; Mihalová R; Březinová J; Hodný Z; Cermáková K; Polanská V; Marinov I; Jedelský PL; Kuželová K; Stöckbauer P
Leuk Res; 2013 Mar; 37(3):320-6. PubMed ID: 23290585
[TBL] [Abstract][Full Text] [Related]
51. A human plasma cell line: induction and characterization.
Miller CH; Carbonell A; Peng R; Paglieroni T; MacKenzie MR
Cancer; 1982 May; 49(10):2091-6. PubMed ID: 6804081
[TBL] [Abstract][Full Text] [Related]
52. Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture.
Jobin ME; Fahey JL; Price Z
J Exp Med; 1974 Aug; 140(2):494-507. PubMed ID: 4858717
[TBL] [Abstract][Full Text] [Related]
53. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
[TBL] [Abstract][Full Text] [Related]
54. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Dunkley S; Gibson J; Iland H; Li C; Joshua D
Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
[TBL] [Abstract][Full Text] [Related]
55. Stability of cytogenetic alterations in a human melanoma cell line and five clonal derivatives.
de Lucca EJ; Pathak S; Cheung MC
Int J Cancer; 1988 Feb; 41(2):297-304. PubMed ID: 3422226
[TBL] [Abstract][Full Text] [Related]
56. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.
Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K
Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782
[TBL] [Abstract][Full Text] [Related]
57. Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma.
Manley R; Monteath J; Patton WN
Clin Lab Haematol; 1999 Feb; 21(1):61-3. PubMed ID: 10197266
[TBL] [Abstract][Full Text] [Related]
58. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
59. TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.
Börset M; Waage A; Brekke OL; Helseth E
Eur J Haematol; 1994 Jul; 53(1):31-7. PubMed ID: 8062895
[TBL] [Abstract][Full Text] [Related]
60. [A case of multiple myeloma (IgG, lambda-type)) with pathological plasmacytes and M-protein in the pleural fluid (author's transl)].
Fukushima K; Ishimi H; Tsutsui D; Morioka S; Nishimura Y; Tanaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Jul; 17(7):415-20. PubMed ID: 119889
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
